You Want To Be Sure Your Gloves or Your Isolators Are Leak Tight

You might also like

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 1

GLT - Glove Leak Test

The isolator glove constitutes the weakest link in a containment barrier. Our GLT system allows glove testing without breaking the isolator's integrity by testing the glove outside. Using the Oxygene rising monitoring technique, the GLT is the most accurate glove testing equipment You want to be sure your gloves or your isolators are leak tight. The glove leak tester (HSPG) is best suited for testing the following: Integrity of the glove/glove sleeve combination Integrity of the isolator The glove leak tester is client specific for the following configurations: Over-pressure glove testing Under-pressure glove testing Over-pressure isolator testing TEST PRINCIPLE With this glove leak tester, it is possible to integrity test up to twelve glove/sleeve combinations at once, without demounting them. Client specific test covers for overpressure or test cylinders for underpressure are provided. A barrier isolator, or simply an isolator, is a device that provides a physical barrier between a laboratory technician and a work process. Isolators are routinely found within the pharmaceutical industry, and with the recent implementation of USP 797 ("Pharmaceutical Compounding: Sterile Preparations", a set of sterile compounding standards issued by the United States Pharmacopeia), are increasingly used in pharmacy applications. They are designed to provide an isolation of a process or the maintenance of an internal condition (e.g., sterile or aseptic). Isolators may operate at positive, negative, or ambient differential pressure. Isolators may provide personnel, product, or environmental protection, or any combination thereof. They are used throughout industry, from orange juice filling lines to cytotoxic drug compounding to electronics manufacturing. Regarding pharmacy applications, because people are the greatest source of contamination during aseptic manufacturing of drugs, reducing personnel interventions into the process zone has significant impact on the efficacy of the final drug product. In the mid-1980s, the industry began to employ barrier isolators, and later, in the 1990s, Restricted Access Barrier Systems, or RABS, to separate people from the process. The acronym RABS was coined by Stewart Davenport of Upjohn (now Pfizer). Since that time, the technology and applications of these systems has developed and broadened significantly.

You might also like